This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: University of Michigan. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Renqi Xu - Innovator in Cancer Treatment
Introduction
Renqi Xu is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of small molecule STAT protein degraders. His work is vital in the ongoing battle against cancer and other related diseases.
Latest Patents
Renqi Xu holds 1 patent for his invention titled "Small molecule STAT protein degraders." This patent provides compounds represented by Formula (I) and their pharmaceutically acceptable salts and solvates. The compounds are designed to target STAT proteins, making them useful in the treatment of cancer and various other diseases.
Career Highlights
Renqi Xu is affiliated with the University of Michigan, where he conducts his research and development. His work at this esteemed institution has allowed him to explore innovative solutions in the medical field, particularly in oncology.
Collaborations
Renqi Xu collaborates with Haibin Zhou, contributing to the advancement of research in their shared field of expertise.
Conclusion
Renqi Xu's contributions to the development of small molecule STAT protein degraders represent a significant advancement in cancer treatment. His innovative work continues to inspire and pave the way for future research in this critical area of medicine.